Skip to main content

Table 1 Demographic characteristics

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

Variable

Overall

Age ≥ 65 years

 

NHANES

Projected national estimate

NHANES

Projected national estimate

 

N = 2915

 

N = 1466

 

Mean (SE) age, years

63.9 (0.2)

61.4 (0.4)

73.4 (0.1)

73.1 (0.1)

Age ≥ 65 years, % (n)

50.3 (1466)

40.3 (N/A)

100 (1466)

100 (N/A)

Sex, % male (n)

52.0 (1517)

50.8 (N/A)

51.8 (760)

47.1 (N/A)

Mean (SE) diabetes duration, years

10.7 (0.2)

9.7 (0.2)

13.2 (0.3)

12.9 (0.3)

Mean (SE) eGFR (CKD-EPI), ml/min/1.73 m2

78.2 (0.5)

80.5 (0.5)

65.3 (0.6)

64.2 (0.8)

Mean (SE) eGFR (MDRD), ml/min/1.73 m2

78.5 (0.5)

79.1 (0.6)

66.7 (0.6)

64.8 (0.8)

Mean (SE) UAE, mg/g

109.7 (1.3)

109.1 (1.4)

103.4 (1.6)

99.1 (1.8)

Race/ethnicity

    

Mexican American, % (n)

21.9 (638)

8.1 (N/A)

18.4 (269)

5.0 (N/Aa)

Other Hispanic, % (n)

7.9 (231)

5.9 (N/A)

6.0 (88)

3.4 (N/Aa)

Non-Hispanic white, % (n)

37.9 (1105)

62.6 (N/A)

47.0 (689)

72.6 (N/Aa)

Non-Hispanic black, % (n)

26.5 (773)

15.9 (N/A)

23.1 (338)

12.4 (N/Aa)

Other, including multiracial, % (n)

5.8 (168)

7.4 (N/A)

5.6 (82)

6.5 (N/Aa)

Comorbidities (self-reported)

    

Hypertension, % (n)a

74.0 (2157)

71.9 (N/A)

80.3 (1177)

80.9 (N/Aa)

Retinopathy, % (n)

22.1 (645)

20.9 (N/A)

23.1 (339)

22.2 (N/Aa)

Coronary heart disease, % (n)

12.0 (351)

12.5 (N/A)

16.6 (243)

19.9 (N/Aa)

Myocardial infarction, % (n)

12.7 (371)

12.0 (N/A)

16.5 (241)

18.2 (N/Aa)

Congestive heart failure, % (n)

11.2 (326)

10.6 (N/A)

15.5 (227)

16.9 (N/Aa)

Angina, % (n)

9.0 (261)

9.5 (N/A)

11.4 (167)

13.9 (N/Aa)

Stroke, % (n)

10.1 (293)

9.1 (N/A)

13.6 (200)

14.4 (N/Aa)

  1. aN = 21,318,626 based on the total number of persons with diabetes who were age ≥ 18 years, NHIS 2012.